Glass House Brands (GLAS) Change in Cash (2020 - 2026)
Glass House Brands' (GLAS) quarterly Change in Cash came in at $4.6 million in Q1 2026, up 561.42% year-on-year from $692000.0 in Q1 2025, and up 171.28% on a QoQ basis from -$6.4 million in Q4 2025.
Glass House Brands (GLAS) Change in Cash (2020 - 2026) Analysis & Trends
Glass House Brands (GLAS) has 7 years of Change in Cash data on file, last reported at $4.6 million in Q1 2026.
- On a quarterly basis, Change in Cash rose 561.42% year-over-year to $4.6 million in Q1 2026; TTM through Mar 2026 was -$9.7 million, a 173.36% decrease from a year earlier, with the FY2025 full-year figure at -$13.6 million, down 408.55% from the prior year.
- Change in Cash for Q1 2026 stood at $4.6 million, up from -$6.4 million in the prior quarter.
- Over the last five years, Change in Cash for GLAS reached as high as $23749.3 billion in Q3 2023 and fell as low as -$29234.1 billion in Q4 2022.
- Historically, Change in Cash has averaged -$322.6 billion across 5 years, with a median of $4.6 million in 2026.
- Across the five-year window, Change in Cash surged 27940376370.59% in 2023 and slumped 444.66% in 2025, its largest moves.
- Year by year, Change in Cash stood at -$29234.1 billion in 2022, then jumped by 100.0% to $32.5 million in 2023, then tumbled by 94.27% to $1.9 million in 2024, then slumped by 444.66% to -$6.4 million in 2025, then surged by 171.28% to $4.6 million in 2026.
- Per Business Quant data, the three most recent Change in Cash figures were $4.6 million in Q1 2026, -$6.4 million in Q4 2025, and -$14.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 185.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | -509.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -388.85 Mn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | -277.40 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 457.70 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | -446.50 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | -117.00 Mn |
| 10 | Glass House Brands | 873.84 Mn | 845.91 Mn | 10.02 Mn | 4.58 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.58 Mn |
| Dec 31, 2025 | -6.42 Mn |
| Sep 30, 2025 | -14.43 Mn |
| Jun 30, 2025 | 6.59 Mn |
| Mar 31, 2025 | 692,000.00 |
| Dec 31, 2024 | 1.86 Mn |
| Sep 30, 2024 | 9.18 Mn |
| Jun 30, 2024 | 1.47 Mn |
| Mar 31, 2024 | -8.12 Mn |
| Dec 31, 2023 | 32.52 Mn |
| Sep 30, 2023 | 23,749.32 Bn |
| Jun 30, 2023 | 22.69 Mn |
| Mar 31, 2023 | 16.37 Mn |
| Dec 31, 2022 | -29,234.08 Bn |
| Sep 30, 2022 | 85,000.00 |
| Jun 30, 2022 | 17.45 Mn |
| Mar 31, 2022 | 24.83 Mn |
| Dec 31, 2021 | 49,531.58 Bn |
| Sep 30, 2021 | 104.51 Mn |
| Jun 30, 2021 | 122.67 Mn |